OCMO Webinar - Informed Care in Psychiatric Medication Use and Withdrawal Fecha y hora 3 jun 2026 03:00 p. m.

https://zoom.us/webinar/register/WN_A_RgmmwtTy2lY22iGnmvoA?utm_source=SAMHSA&utm_campaign=a9ce11e3ce-EMAIL_CAMPAIGN_2026_05_11_01_40&utm_medium=email&utm_term=0_-a9ce11e3ce-167840245#/registration CME/CEU Credits Available. This activity is designated for 1.0 CEUs or 1.0 AMA PRA Category Credits™. SAMHSA’s Office of the Chief Medical Officer will host a webinar titled “Informed Care in Psychiatric Medication Use and Withdrawal”. The event will feature Matthew Rudorfer, MD; Mark Horowitz, MD, PhD; and Laura Delano. The webinar will explore a range of psychiatric treatment options and strategies to support fully informed care, including understanding benefits, potential risks, dependence, and withdrawal considerations. Presenters will discuss emerging perspectives in the field, highlight current evidence, and examine approaches that promote collaborative decision-making between providers and patients. Following the presentations, attendees will have the opportunity to participate in a moderated question-and-answer segment. Questions will be addressed in the order received, with priority given to those submitted during registration. The webinar is open to all, but registration is required. Presenters: Matthew Rudorfer, MD, is Chief of the Psychopharmacology, Somatic, and Integrated Treatments Research Program in the Treatment and Preventive Interventions Research Branch within the Division of Services and Intervention Research at the National Institute of Mental Health. Mark Horowitz, MD, PhD, is an Associate Professor of Psychiatry at the University of Adelaide, a Visiting Lecturer in Psychopharmacology at King’s College London, and the lead of the National Psychotropic Deprescribing Clinic within the United Kingdom’s National Health Service. Laura Delano is an author, speaker, and consultant, and the founder of Inner Compass Initiative, a nonprofit organization that supports informed decision-making about psychiatric drugs and promotes non-medicalized approaches to human distress. In support of improving patient care, the Substance Abuse and Mental Health Services Administration is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide interprofessional collaborative continuing education (IPCE) activities for the healthcare team. IPCE activity credits are accepted as CME for medical practitioners, and CE for dieticians, nurses, pharmacists, physician associates/physician assistants, psychologists, and social workers. The activity was planned by and for the healthcare team. Please note: Organizations, not individual courses, are approved under this program. Regulatory boards are the final authority on courses accepted for continuing education credit. As a Jointly Accredited Organization, the Substance Abuse and Mental Health Services Administration is approved to offer social work continuing education by the Association of Social Work Boards (ASWB) Approved Continuing Education (ACE) program. Organizations, not individual courses, are approved under this program. Regulatory boards are the final authority on courses accepted for continuing education credit. Social workers completing this course receive 1.0 CEU continuing education credits. Continuing Education (CE) credits for psychologists are provided through the co-sponsorship of the American Psychological Association (APA) Office of Continuing Education in Psychology (CEP). The APA CEP Office maintains responsibility for the content of the programs. The views, opinions, and content expressed in this presentation do not necessarily reflect the views, opinions, or policies of the Substance Abuse and Mental Health Services Administration or the U.S. Department of Health and Human Services (HHS). Questions may be directed to SAMHSAStateTA@JBSInternational.com